Literature DB >> 29353210

VPg unlinkase/TDP2 in cardiovirus infected cells: Re-localization and proteolytic cleavage.

Sonia Maciejewski1, Wendy Ullmer1, Bert L Semler2.   

Abstract

Cardioviruses cause diseases in many animals including, in rare cases, humans. Although they share common features with all picornaviruses, cardioviruses have unique properties that distinguish them from other family members, including enteroviruses. One feature shared by all picornaviruses is the covalent attachment of VPg to the 5' end of genomic RNA via a phosphotyrosyl linkage. For enteroviruses, this linkage is cleaved by a host cell protein, TDP2. Since TDP2 is divergently required during enterovirus infections, we determined if TDP2 is necessary during infection by the prototype cardiovirus, EMCV. We found that EMCV yields are reduced in the absence of TDP2. We observed a decrease in viral protein accumulation and viral RNA replication in the absence of TDP2. In contrast to enterovirus infections, we found that TDP2 is modified at peak times of EMCV infection. This finding suggests a unique mechanism for cardioviruses to regulate TDP2 activity during infection.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5′ tyrosyl-DNA phosphodiesterase 2; Cardiovirus; EMCV; Encephalomyocarditis virus; Picornavirus; TDP2; Virus-host interactions

Mesh:

Substances:

Year:  2018        PMID: 29353210      PMCID: PMC5826889          DOI: 10.1016/j.virol.2018.01.010

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  51 in total

1.  Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase.

Authors:  W S Blair; B L Semler
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

2.  The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection.

Authors:  Laura Papon; Alexandra Oteiza; Tadaatsu Imaizumi; Hiroki Kato; Emiliana Brocchi; T Glen Lawson; Shizuo Akira; Nadir Mechti
Journal:  Virology       Date:  2009-09-04       Impact factor: 3.616

3.  [Characteristics of an enzyme hydrolyzing the covalent bond between RNA and protein VPg of the encephalomyocarditis virus].

Authors:  Iu F Drygin; E Iu Siianova
Journal:  Biokhimiia       Date:  1986-02

4.  Leader protein of encephalomyocarditis virus binds zinc, is phosphorylated during viral infection, and affects the efficiency of genome translation.

Authors:  C M Dvorak; D J Hall; M Hill; M Riddle; A Pranter; J Dillman; M Deibel; A C Palmenberg
Journal:  Virology       Date:  2001-11-25       Impact factor: 3.616

5.  Differential cleavage of IRES trans-acting factors (ITAFs) in cells infected by human rhinovirus.

Authors:  Amanda J Chase; Bert L Semler
Journal:  Virology       Date:  2013-11-21       Impact factor: 3.616

6.  Encephalomyocarditis virus 2A protein is required for viral pathogenesis and inhibition of apoptosis.

Authors:  M Carocci; N Cordonnier; H Huet; A Romey; A Relmy; K Gorna; S Blaise-Boisseau; S Zientara; L Bakkali Kassimi
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

7.  Leader-induced phosphorylation of nucleoporins correlates with nuclear trafficking inhibition by cardioviruses.

Authors:  Frederick W Porter; Ann C Palmenberg
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

8.  Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex.

Authors:  D Etchison; S C Milburn; I Edery; N Sonenberg; J W Hershey
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

9.  TDP2 promotes repair of topoisomerase I-mediated DNA damage in the absence of TDP1.

Authors:  Zhihong Zeng; Abhishek Sharma; Limei Ju; Junko Murai; Lieve Umans; Liesbeth Vermeire; Yves Pommier; Shunichi Takeda; Danny Huylebroeck; Keith W Caldecott; Sherif F El-Khamisy
Journal:  Nucleic Acids Res       Date:  2012-06-26       Impact factor: 16.971

10.  Reversal of DNA damage induced Topoisomerase 2 DNA-protein crosslinks by Tdp2.

Authors:  Matthew J Schellenberg; Lalith Perera; Christina N Strom; Crystal A Waters; Brinda Monian; C Denise Appel; Caroline K Vilas; Jason G Williams; Dale A Ramsden; R Scott Williams
Journal:  Nucleic Acids Res       Date:  2016-04-08       Impact factor: 16.971

View more
  3 in total

1.  Novel deazaflavin tyrosyl-DNA phosphodiesterase 2 (TDP2) inhibitors.

Authors:  Evgeny Kiselev; Azhar Ravji; Jayakanth Kankanala; Jiashu Xie; Zhengqiang Wang; Yves Pommier
Journal:  DNA Repair (Amst)       Date:  2019-11-06

2.  Triazolopyrimidine and triazolopyridine scaffolds as TDP2 inhibitors.

Authors:  Carlos J A Ribeiro; Jayakanth Kankanala; Jiashu Xie; Jessica Williams; Hideki Aihara; Zhengqiang Wang
Journal:  Bioorg Med Chem Lett       Date:  2018-11-22       Impact factor: 2.823

Review 3.  Human topoisomerases and their roles in genome stability and organization.

Authors:  Yves Pommier; André Nussenzweig; Shunichi Takeda; Caroline Austin
Journal:  Nat Rev Mol Cell Biol       Date:  2022-02-28       Impact factor: 113.915

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.